A nasal spray that forms a barrier against COVID-19 is due to be launched locally next week, providing a secondary layer of protection, particularly in crowded, enclosed and high-risk settings.
Touted as an additional, clinically-proven tool in the battle against the coronavirus, the Israeli product, Taffix™ (Powder) Spray Device, claims to offer 97 per cent shielding from respiratory viruses in the nasal cavity – also blocking SARS-CoV-2.
Every application works within 50 seconds and gives five-hour protection, the manufacturer, Nasus Pharma said.
It insists, however, that intra-nasal antiviral protection does not replace the wearing of face masks. The company strongly recommends it is used in addition to other preventative health measures, including social distancing, regular hand washing and compliance with other government restrictions.
The vaccine conundrum: weighing the risks of a rare side effect
Despite scientists trying to explain that all medicines have probable side effects, even pointing out that taking the contraceptive pill and taking a flight have a higher probability of causing blood clots, the fear continues to prevail
Josanne Cassar
12 April 2021, 7:15am
The Malta Employers’ Association this week came out with the proposal that those employees who refuse to take the vaccine should have to accept regular mandatory swab tests at their own expense and should not be paid for any quarantine leave should they test positive.
This controversial suggestion is obviously going to cause a furore, because it impinges on a person’s rights to refuse the vaccine, however the MEA’s argument is that employers also have the right to safeguard their workplace. While I can understand both points of view, I still cannot grasp why there is resistance to a vaccine which can perhaps get us back to life as w
Watch live: Charmaine Gauci holds COVID-19 briefing timesofmalta.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesofmalta.com Daily Mail and Mail on Sunday newspapers.
Health Minister Chris Fearne has asked Mater Dei s chief medical officer to look into claims that a healthy woman died three weeks after she was given the AstraZeneca vaccine.
The victim s husband said his 67-year-old wife died of a blood clot three weeks after getting the AstraZeneca vaccine. He also claimed she was perfectly healthy before her death, according to an online report in the digital platform SideStreet.
The report says the couple received their vaccine on March 13, before the woman became feverish and died on Easter Sunday.
Times of Malta has tried to reach out to the woman s family but they have refused to give any further comments.
Interim Statement by the Malta Medicines Authority on AstraZeneca COVID-19 Vaccine (Vaxzevria) maltawinds.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from maltawinds.com Daily Mail and Mail on Sunday newspapers.